Related Experiment Video
Updated: Aug 6, 2026

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature
Published on: January 24, 2025
Aldose reductase gene is associated with diabetic macroangiopathy in Japanese Type 2 diabetic patients
A Watarai1, E Nakashima, Y Hamada
1Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Aims:
The aldose reductase (AR) gene, a rate-limiting enzyme of the polyol pathway, has been investigated as a candidate gene in determining susceptibility to diabetic microangiopathy. However, the association of the AR gene with diabetic macroangiopathy has not been investigated. Therefore, the present study was conducted to determine whether genetic variations of AR may determine susceptibility to diabetic macroangiopathy.
Methods:
There were 378 Type 2 diabetic patients enrolled in this study. A single nucleotide polymorphism in the promoter region (C-106T) was genotyped and the AR protein content of erythrocytes measured by ELISA.
Results:
There were no significant differences in genotypic or allelic distribution in patients with or without ischaemic heart diseases, but there was a significant increase in the frequency of the CT + TT genotype and T allele in patients with stroke (P = 0.019 and P = 0.012). The erythrocyte AR protein content was increased in patients with the CT and TT genotype compared with those with the CC genotype. After adjustment for age, duration of diabetes, body mass index, systolic blood pressure, HbA1c, and serum creatinine, triglycerides, and total cholesterol in multivariate logistic-regression models, the association between this AR genotype and stroke remained significant.
Conclusions:
Our results suggest that the CT or TT genotype of the AR gene might be a genetic marker of susceptibility to stroke in Type 2 diabetic patients. This observation might contribute to the development of strategies for the prevention of stroke in Type 2 diabetic patients.
Insights
Genetic variations in the aldose reductase (AR) gene, specifically the CT or TT genotype, are linked to an increased risk of stroke in Type 2 diabetic patients. This finding may aid in developing future stroke prevention strategies.
Area of Science:
- Genetics
- Metabolic Disorders
- Cardiovascular Disease
Background:
- The aldose reductase (AR) gene is crucial in the polyol pathway and has been linked to diabetic microangiopathy.
- The association between AR gene variations and diabetic macroangiopathy, particularly stroke, remains under-investigated.
- Understanding genetic predispositions can inform personalized medicine approaches for diabetes complications.
Purpose of the Study:
- To investigate the association between genetic variations in the aldose reductase (AR) gene and susceptibility to diabetic macroangiopathy.
- Specifically, to determine if AR gene polymorphisms influence the risk of stroke in Type 2 diabetic patients.
- To explore the relationship between AR genotype and AR protein levels in erythrocytes.
Main Methods:
- Genotyping of a single nucleotide polymorphism (C-106T) in the promoter region of the AR gene in 378 Type 2 diabetic patients.
- Measurement of erythrocyte aldose reductase (AR) protein content using ELISA.
- Statistical analysis, including logistic regression, to assess the association between AR genotype and stroke risk, adjusted for clinical factors.
Main Results:
- No significant association was found between AR gene polymorphisms and ischaemic heart disease.
- A significant increase in the frequency of the CT + TT genotype and T allele of the AR gene was observed in patients with stroke.
- Erythrocyte AR protein content was elevated in individuals with the CT and TT genotypes compared to the CC genotype, with the association between AR genotype and stroke remaining significant after multivariate adjustment.
Conclusions:
- The CT or TT genotype of the aldose reductase (AR) gene may serve as a genetic marker for stroke susceptibility in Type 2 diabetic individuals.
- These findings could contribute to the development of targeted strategies for stroke prevention in diabetic populations.
- Further research is warranted to elucidate the precise mechanisms linking AR gene variations to stroke risk.
Related Concept Videos
Diabetic Retinopathy
Diabetes Mellitus: Type 2 and Gestational
Diabetic Nephropathy
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...